Search

A first-in-kind kidney cancer drug developed from laboratory and translational studies conducted at UT Southwestern Medical Center received approval from the Food and Drug Administration, providing a new treatment for patients with familial kidney cancer.

A study of gene activity in the brain’s hippocampus, led by UT Southwestern researchers, has identified marked differences between the region’s anterior and posterior portions.

Information for media relations with UT Southwestern

UT Southwestern researchers have discovered a mechanism that cells use to degrade microRNAs (miRNAs), genetic molecules that regulate the amounts of proteins in cells.

Stories published in 2025 about UT Southwestern Medical Center.

UT Southwestern Medical Center is collaborating with Pfizer Inc. to develop RNA enhanced delivery technologies for genetic medicine therapies through the Dallas-based medical center’s Program in Genetic Drug Engineering.

The CLOCK gene, which serves as a master controller of circadian rhythms, may play a key role in the extraordinary cognitive abilities of humans as well as neuropsychiatric disorders that afflict them, UT Southwestern Medical Center researchers report.

A new robotic surgery device allows for all of the necessary surgical tools to be inserted through one 1-inch hole, whereas standard laparoscopic surgery requires five or six small incisions.

 UT Southwestern is the only clinical trial site in the U.S. using a new form of brain stimulation to treat major depression.

UT Southwestern Medical Center scientists for the first time have calculated and mapped life expectancy by gender and race/ethnicity down to the ZIP code and county levels in Texas.